Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
-
Market Cap
60.30M
Enterprise Value
55.97M
Income
2.72M
Sales
172.14M
Book/sh
2.64
Cash/sh
1.08
Employees
223
IPO
Apr 07, 1994
P/E
22.08
Forward P/E
-
PEG
-
P/S
0.35
P/B
1.80
P/C
4.39
P/FCF
6.92
EV/EBITDA
8.49
EV/Sales
0.33
Quick Ratio
1.12
Current Ratio
1.91
Debt/Eq
0.28
LT Debt/Eq
0.22
Option/Short
Yes / Yes
EPS (ttm)
0.22
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
25.48% -15.07%
Sales past 3/5Y
-5.07% -3.68%
EPS Y/Y TTM
-73.68%
Sales Y/Y TTM
-24.79%
EPS Q/Q
-109.43%
Sales Q/Q
-21.96%
Insider Own
18.75%
Insider Trans
-1.14%
Inst Own
51.84%
Inst Trans
-1.42%
ROA
4.51%
ROE
8.19%
ROIC
6.68%
Gross Margin
76.54%
Oper. Margin
2.15%
Profit Margin
1.58%
SMA20
-10.92%
SMA50
-18.04%
SMA200
-18.57%
Trades
Shs Outstand
12.59M
Shs Float
10.30M
52W High
11.71 -59.39%
52W Low
3.90 21.92%
Volatility
9.10% 6.68%
ATR (14)
0.35
RSI (14)
34.17
Beta
0.77
Rel Volume
1.62
Avg Volume
44.64K
Volume
60,169
Perf Week
-5.65%
Perf Month
-20.08%
Perf Quarter
-28.92%
Perf Half Y
-11.45%
Perf YTD
-22.81%
Perf Year
-25.70%
Perf 3Y
-15.54%
Perf 5Y
-32.01%
Perf 10Y
-43.48%
Prev Close
4.81
Price
4.76
Change %
-1.14%
Consensus
Buy
Avg. Price Target
$6.50
Implied Upside
+36.7%
Analysts4incl. previous ratings
Rating Distribution3 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jan 14, 2025Initiated
CCraig Hallum
Buy$35+636.1%
Dec 19, 2024Initiated
LLake Street
Buy$26+446.8%
Sep 08, 2014Initiated
MMidtown Partners
Buy$1.43-69.9%
Feb 12, 2014Initiated
IImperial Capital
In-line$2.10-55.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEINDORFF MICHAEL ADirectorNov 12 '26Sale4.8910,00048,86131,625Nov 16 04:05 PM
BEINDORFF MICHAEL ADirectorNov 12 '26Proposed Sale4.7210,00047,200Nov 12 10:42 AM
Lewis DarwinDirectorSep 15 '26Buy6.229766,071138,244Sep 17 04:05 PM
Cunningham KristenChief Sales OfficerSep 14 '26Sale6.188,90155,008120,162Sep 14 06:55 PM
Cunningham KristenChief Sales OfficerSep 11 '26Sale6.41100641129,063Sep 14 06:55 PM
Lewis DarwinDirectorJun 15 '26Buy8.607056,059137,268Jun 17 04:05 PM
BEINDORFF MICHAEL ADirectorJun 03 '26Sale8.5510,00085,45941,625Jun 05 04:05 PM
BEINDORFF MICHAEL ADirectorJun 03 '26Proposed Sale8.7310,00087,300Jun 03 10:59 AM
Lewis DarwinDirectorMar 16 '26Buy5.231,0555,518136,563Mar 18 04:30 PM
Dayton JuddDirectorFeb 27 '26Buy4.6318,09783,78969,859Mar 02 06:44 PM
Dayton JuddDirectorMar 02 '26Buy4.5310,50047,56580,359Mar 02 06:44 PM
Dayton JuddDirectorFeb 26 '26Buy4.584,60021,06851,762Mar 02 06:44 PM
Lewis DarwinDirectorFeb 09 '26Buy5.223,95520,651135,508Feb 11 04:32 PM
Lewis DarwinDirectorDec 15 '25Buy6.548055,265131,553Dec 17 04:23 PM
LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.
Chief Financial OfficerMr. Carl A. Aure CPA
Chief Sales OfficerMs. Kristen Cunningham
PresidentMr. Terrence O. Moorehead
Chief Technology OfficerMr. Mike Edwards
Chief People OfficerMs. Michelle Oborn-Virchow